Granted Patent B2

US 12,630,869 · App. 18/331,043 · Granted May 19, 2026

Inventors: Joseph M. Beechem (Eugene, OR); Charles Warren (Bremerton, WA); Chris Merritt (Seattle, WA); Jaemyeong Jung (Bellevue, WA); Dwayne L. Dunaway (Seattle, WA); Scott Crowder (Seattle, WA); Kristina Sorg (Seattle, WA); Gordon B. Mills (Houston, TX)

Assignees: Board of Regents, The University of Texas System; Bruker Spatial Biology, Inc.

C12Q1/6841C12Q1/6823G01N33/6845

Abstract

Claims (32)

1 . A method comprising:

(1) contacting at least one nucleic acid target in or from at least one cell in a sample with at least one probe comprising a target-binding domain and a signal oligonucleotide;

(2) providing a force to a location of the sample sufficient to release the signal oligonucleotide; and

(3) collecting and identifying the released signal oligonucleotide, thereby detecting the at least one nucleic acid target in or from a specific location of the sample that was provided the force.

2 . The method of claim 1 , wherein detecting comprises determining the identity and the abundance of the at least one nucleic acid target.

3 . The method of claim 2 , wherein the at least one nucleic acid target comprises at least two distinct nucleic acid targets or at least two copies of the same nucleic acid target, and wherein detecting comprises comparing the abundance of each distinct nucleic acid target.

4 . The method of claim 1 , further comprising repeating at least steps (2) and (3) on at least a second specific location of the sample, the second specific location comprising at least a second cell, wherein detecting comprises comparing the abundance of the at least one nucleic acid target in or from the specific location and in or from the at least second specific location.

5 . The method of claim 4 , wherein the at least one cell and the at least second cell:

a) are the same cell type;

b) are distinct cell types; or

c) are independently selected from a normal cell and an abnormal cell.

6 . The method of claim 4 , wherein detecting comprises comparing the abundance of the at least one nucleic acid target in or from the at least first cell type and in or from the at least second cell type.

7 . The method of claim 1 , wherein the at least one cell is directly immobilized to a surface or is indirectly immobilized to the surface via at least one other cell.

8 . The method of claim 1 , wherein the at least one cell is a cultured cell, a primary cell, or a dissociated cell from an explant, and wherein the at least one cell is fixed or unfixed.

9 . The method of claim 1 , wherein the at least one probe further comprises a linker located between the target-binding domain and the signal oligonucleotide, wherein the linker comprises a photo-cleavable linker.

10 . The method of claim 1 , wherein the provided force is light from a light source selected from the group consisting of an arc-lamp, a laser, a focused UV light source, and light emitting diode (LED).

11 . The method of claim 1 , wherein the nucleic acid target is DNA or RNA.

12 . The method of claim 1 , wherein the released signal oligonucleotide is collected from a solution proximal to the at least one cell.

13 . The method of claim 1 , wherein the released signal oligonucleotide is collected from a solution proximal to the at least one cell by aspirating via a pipette, a capillary tube, a microarray pin, and/or a flow cell comprising holes.

14 . The method of claim 1 , wherein the method further comprises illuminating a region of interest using a laser scanning device or a digital mirror device (DMD).

15 . The method of claim 1 , wherein the probe is provided at a concentration of 5 nM or less, 1 nM or less, 0.4 nM or less, or 0.2 nM or less.

16 . A system comprising:

a) a mounted biological sample complexed with one or more nucleic acid probes, each nucleic acid probe comprising a target-binding domain, a signal oligonucleotide, and a photo-cleavable motif located between the target-binding domain and the signal oligonucleotide,

wherein the biological sample is in a solution comprising at least one released signal oligonucleotide;

b) a visible-light based imaging system; and

c) a capillary tube.

17 . The system of claim 16 , wherein the visible-light based imaging system comprises a microscope.

18 . The system of claim 16 , wherein the visible-light based imaging system comprises a light source selected from the group consisting of an arc-lamp, a laser, a focused UV light source, and light emitting diode (LED).

19 . A complex comprising:

a) a target nucleic acid, and

b) one or more nucleic acid probes bound to the target nucleic acid, each nucleic acid probe comprising a target-binding domain, a signal oligonucleotide, and a photo-cleavable motif located between the target-binding domain and the signal oligonucleotide.

20 . The complex of claim 19 , wherein the complex is mounted on a solid support.

Assignments (8)

Continuity (7)

References Cited (400)